How can vincristine be fatal to a cell
5072 increased the intracellular electrochemical potential for methotrexate. The effect of vincristine on the interaction between methotrexate and Ehrlich ascites tumor cells is comparable to that observed for azide, an inhibitor of aerobic metabolism, in these cells as well as in the L1210 leukemia cell 5 ; . Both agents depress the unidirectional efflux of methotrexate, increase the exchangeable intracellular methotrexate fraction, and appear to increase uphill transport into the cell. However, while aaide produces a small increase in the unidirectional influx of methotrexate, such a change could not be demonstrated for vincristine at levels up to 30 ELM. Many structurally diverse compounds with different sites of action, iodoacetate, azide, antimycin A, dinitrophenol, inhibit energy metabolism and enhance net uptake of methotrexate a similar effect was observed with anaerobiosis ; 5 ; . The metabolic effects of agents which inhibit aerobic metabolism should be antagonized by glucose as a result of glycolytic production of ATP which compensates for impaired oxidative ATP formation. Accordingly, alterations in the sodium and potassium content of Ehrlich ascites tumor cells induced by antimycin A, and the reduction in the cellular ATP level induced by amytal or dinitrophenol, are eliminated by glucose 13 ; . Likewise, glucose completely reversed the effect of azide on met, hotrexate uptake in these studies. Hence, it is of particular interest that glucose partially reversed the vincristine-induced increase in methotrexate uptake. The similarity between the effects of azide and vincristine suggests that vincristine inhibits energy metabolism and that it is by this mechanism that this agent alters methotrexate uptake. Because glucose partially reverses the effect of vincristine, the data suggest that vincristine may inhibit aerobic energy metabolism; however, since glucose reversal is not complete, vincristine may also inhibit anaerobic energy metabolism. Additional evidence that vincristine may inhibit energy-dependent processes comes from the observation that this agent like other metabolic poisons reduces the uphill transport of the nonmetabolized amino acid analogue cy-aminoof isobutyric acid, into Ehrlich ascites tumor cells.4 Inhibition both anaerobic and aerobic energy metabolism by vinca alkaloids, at concentrations comparable to those employed in these studies, has been reported for L1210 and Ehrlich ascites tumor cells 14 ; . Periwinkle alkaloids bind with high affinity 15 ; to protein subunits of microtubules to form protein-drug precipitates 16-18 ; which arc thought to be the filamentous structures and crystals that are observed on electron microscopy 19-21 ; . This interaction results in impaired formation of mitotic spindles 22-24 ; and in the arrest of cell division in metaphase 25, 26 ; which is considered to be the basis of the cytotosicity of these agents. It is unlikely that impaired spindle formation can account for the effects of vincristinc on methotrexate uptake. I-Icnce, although 10 vincristinc or vinblastinc produce crystal formation on electron microscopy within 55 hour after exposure of L-cell mouse fibroblasts t.o these agents 19 ; , over this interval there are no significant changes in methotrexate uptake. Further, alt.hough the L1210 leukemia and the Ehrlich ascitcs tumors are very sensitive to the stimulatory effect of vincristine on methotrexate uptake, vincristine negligibly affects survival of mice bearing these tumors 6, 27 ; and over an interval of exposure of L-cells to vincristine sufhcicnt to arrest cell replication a significant change in methotrexate uptake is not demonstrable. Vinca alkaloids interact with other microtubular proteins. Marginal bundles of.
How can vincristine be fatal to a cell
Vincristine may also interfere with cell's ability to synthesize dna and rna the physical parameters of vincristine are shown in the table below.
Figs. 11, 12. Effect of vincristine on [ 3 H]norepinephrine accumulation. Glutaraldehyde fixation. 12 days in vitro. Fig. 11. Control culture pulsed with 5 iCi i2S ng ; ml [ * H]norepinephrine for 60 min. Fig. 12. Vincristine-treated culture exposed to 10 Jg vincristine sulphate for 18 h then pulsed with 5 Ci i25 ng ; ml [ H]norepinephrine for 60 min. Figs. 13-16 are electron micrographs of sympathetic neurons grown in tissue culture for 14 days. Fig. 13. Neuronal cell body in a culture exposed to 10 fig ml vincristine sulphate for 17 h. The large crystal-like structure c ; and the absence of microtubules distinguish drug-treated cells from controls. With the exception of a few damaged mitochondria m ; , other cellular organelles are not noticeably disrupted. Numerous neurofilaments and a few dense-core vesicles are in the cytoplasm.
INTRODUCTION The treatment of any of a wide variety of cells with vincristine or vinblastine results in the dissolution of cytoplasmic microtubules and the formation of both 90-100 A filaments and ordered arrays of hexagonally packed, circular structures 1-4 ; . These ordered structures have been named "microtubular crystals" 2, 3 ; , and this nomenclature will be followed here with the awareness that conclusive evidence of true crystalline order is lacking. Ultracentrifugal studies by Weisenberg and Timasheff 5 ; revealed a vinblastine-induced aggregation of purified microtubule subunit protein. Vinblastine selectively and quantitatively precipitates microtubule protein from supernatants of cell and tissue homogenates, if adequate concentrations of vinblastine and magnesium are used 6, 7 ; . Electron microscopic studies of vinblastineprecipitated microtubule protein were previously reported from this laboratory 8 ; . These studies on embedded, sectioned material revealed ordered acriform arrays of ladder-like structures with "rungs" spaced approximately 300 A apart surrounding circular profiles with a diameter on the order of 360 A . On the basis of this sectioned material it was not possible to ascertain what relationship, if any, existed between the vinblastine-induced precipitated microtubule protein in vitro and the vinblastine-induced microtubular crystals seen in vivo . The negative contrast studies which we now report demonstrate the remarkable similarity between the structures induced by vinblastine in vitro and in vivo. In addition, the three-dimensional structure of the former is clarified, and the results are extrapolated to the latter.
70, 834, 158.90 FIRE EXTINGUISHER, A.T.F, BODY FILLER, WAX, CARB 7 CHOKE, DASHBOARD POLISH, TAPE, FLUID, MOTO GUARDIAN GUARDIAN 70, 849, 758.90 CHEMICAL - 40MT CALICUM CHLORIDE 77-80% FOOD GRADE 70, 857, 758.90 TELECOMMS - SATELLITE SPACE SEGEMENT PAYMENT 71, 524, 828.08 000KG SPRAYGUM SELECTED IRX 72, 841, 749.01 U.S. NO. 2 HARD RED WINTER WHEAT 72, 855, 068.10 CATERPILLAR SPARE PARTS 72, 966, 952.72 IMPORT OF VACUUM FLASK SPARE REFILLS GUARDIAN IBTC IBTC MBC TRIUMPH.
Vincristine ventura
The District participates in the State School Deferred Maintenance Program, which provides State matching funds on a dollar-for-dollar basis, to assist school districts with expenditures for major repair or replacement of existing school building components. Typically, this includes roofing, plumbing, heating, air conditioning, electrical systems, interior or exterior painting, and floor systems. For the 2004-05 school year, the District budgeted 0, 000 for the deferred maintenance program. This represents 0.57% of the District's general fund budget and vinorelbine.
Vincristine tabs
VIDEX .7 VIDEX EC 125mg capsule .7 vinatal forte . 57 vinate az, gt, ii, m, ultra . 57 vinblastine . 19 vincristine . 19 vinorelbine . 19 VIOKASE . 44 VIRACEPT .7 VIRAMUNE .7 VIRAZOLE . 10 VIREAD .7 VISICOL . 43 vis-phos n. 53 visqid a a . VISTIDE . 10 vistra 650 . 20 VISUDYNE . 60 vitafol ob, pn. 57 VITAMINS, MINERALS & RELATED PRODUCTS . 53 VIVACTIL . 26 VIVELLE, VIVELLE DOT . 55 VIVOTIF BERNA . 46 VOLTAREN . 60 VUMON. 19 vynatal fa . 57 VYTORIN . 30 warfarin. 52 water for irrigation . 51 WELCHOL . 31 westhroid. 42 XALATAN . 58 XOLAIR . 62 x-viate . 37.
AN INQUIRY-BASED APPROACH TO PROFESSIONAL DEVELOPMENT AND INSTRUCTION Learn practical strategies to accelerate and support all students, but especially low-income and minority students. Learn how inquiry-based professional development is a necessary foundation for inquiry-based instructional practices, including Socratic Seminars, tutorials, and Cornell note-taking. Learn researchdriven strategies based on 27 years of instructional practice. Create supportive learning environments that turn students from passive learners into active classroom contributors and critical thinkers and viracept.
John Donne, out ofhis religious belief, told us that "No man is an island, entire unto himself'. The catastrophe at Chernobyl showed, beyond doubt, not in the realms of faith and belief, but objectively, that. a nuclear catastrophe cannotbe contained as if on island entire unto itself. Stratospheric winds blow, rains fall, andradio active dust enters our food chain. When Bob Dylan's 'hard rain' falls, radioactively dusting the grass eaten by the cows which give milkfor our children, we not only do harm to ourselves but to the next generation too
| Vincristine in caninesRelated drugs by class alkylating agents cisplatin , cyclophosphamide , cytoxan , ifex , ifex , melphalan by condition hodgkin's disease etoposide , procarbazine , velban , vinblastine , vincristine , doxorubicin , more and viread.
Genesis, pp. 93-94. Cf. p. 46. John Sailhamer, "The Messiah and the Hebrew Bible, " Journal of the Evangelical Theological Society 44: 1 March 2001 ; : 5-23. 219See John C. Jeske, "The Gospel Adam and Eve Heard: Genesis 3: 15" Wisconsin Lutheran Quarterly 81: 3 Summer 1984 ; : 182-84; and Walter C. Kaiser Jr., "The Promise Theme and the Theology of Rest, " Bibliotheca Sacra 130: 518 April-June 1973 ; : 135-50.
Vincristine and hemangioma
Division of tumor cells can be inhibited by Vinca alkaloids e.g., vincristine ; . They are naturally found in Catharanthus roseus. Vinca alkaloids are administered by intravenous injection or short infusion for patients with gliomas or primitive nerve neuroektodermal tumors. Compounds based on elemental platinum Platinum compounds cisplatin, carboplatin, oxaliplatin ; bind to DNA and thus inhibit DNA reduplication and cell proliferation. They are used for the treatment of glioma, medulloblastoma, primitive neuroektodermal tumor and germ cell tumors. Topoisomerase inhibitors DNA, the chemical basis of genetic information, is a dynamic molecule that coils and bends within the nucleus of each cell. These coils and bends must be temporarily unwound in order for the tumor cell to be able to replicate the genetic information and then divide. This process is facilitated by enzymes called topoisomerase I and II. Pharmacological inhibition of these enzymes can be used to treat cancer of the brain. Drugs that inhibit topoisomerases were found in plant extracts. The ones in use today mostly are derivatives of the original compounds chemically modified to increase their efficacy and decrease toxicity. Irinotecan Irinotecan is a semisynthetic derivative of camptothecin, an alkaloid extract from certain plants. Various dosing schedules exist. Most commonly, irinotecan is given every three weeks as an intravenous infusion or once every week for four weeks followed by a break of two weeks. It is used for the treatment of malignant gliomas. semisynthetic derivatives of podophyllotoxin, a substance found in mayapple extracts, inhibit the relegation of DNA from the cleavage complex. As mentioned above, DNA intercalators such as anthracyclines interfere with the formation of the cleavage complex. Etoposide Etoposide is a semisynthetic derivative of podophyllotoxin, a substance found in mayapple extracts. It is being used as part of multi-drug regimens against a large number of primary brain tumors. It is given as an infusion several days in a row followed by two to three weeks rest or daily as a tablet and vistaril
|
[1] Asai A, Miyagi Y, Sugiyama A, Gamanuma M, Hong SH, Takamoto S, Nomura K, Matsutani M, Takakura K, Kuchino Y. Negative effects of wild-type p53 and s-myc on cellular growth and tumorigenicity of glioma cells. Implication of the tumor suppressor genes for gene therapy. J Neurooncol 1984; 19: 259 - 68. [2] Camilleri-Broet S, Vanderwerff H, Caldwell E, Hockenbery D. Distinct alterations in mitochondrial mass and function characterize different models of apoptosis. Exp Cell Res 1998; 239: 277 - 92. [3] Cornwell MM, Pastan I, Gottesman MM. Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein. J Biol Chem 1987; 262: 2166 - 70. [4] Fellner S, Bauer B, Miller DS, Schaffrik M, Fankhanel M, Spruss T, Bernhardt G, Graeff C, Farber L, Gschaidmeier H, Buschauer A, Fricker G. Transport of paclitaxel Taxol ; across the blood-brain barrier in vitro and in vivo. J Clin Invest 2002; 110: 1309 - 18. [5] Gong Y, Wang Y, Chen F, Han J, Miao J, Shao N, Fang Z, Ou Yang R. Identification of the subcellular localization of daunorubicin in multidrug-resistant K562 cell line. Leuk Res 2000; 24: 769 - 74. [6] Gupta N, Hu LJ, Deen DF. Cytotoxicity and cell-cycle effects of paclitaxel when used as a single agent and in combination with ionizing radiation. Int J Radiat Oncol Biol Phys 1997; 37: 885 - 95. [7] Hong FD, Chen J, Donovan S, Schneider N, Nisen PD. Taxol, vincristine or nocodazole induces lethality in G1-checkpointdefective human astrocytoma U373MG cells by triggering hyperploid progression. Carcinogenesis 1999; 20: 1161 - 8. [8] Huet S, Chapey C, Robert J. Reversal of multidrug resistance by a new lipophilic cationic molecule, S9788. Comparison with 11 other MDR-modulating agents in a model of doxorubicin-resistant rat glioblastoma cells. Eur J Cancer 1993; 29A: 1377 - 83. [9] Jensen RL, Origitano TC, Lee YS, Weber M, Wurster RD. In vitro growth inhibition of growth factor-stimulated meningioma cells by calcium channel antagonists. Neurosurgery 1995; 36: 365 - 73. [10] Jensen RL, Wurster RD. Calcium channel antagonists inhibit growth of subcutaneous xenograft meningiomas in nude mice. Surg Neurol 2001; 55: 275 - 83. [11] Karbowski M, Spodnik JH, Teranishi M, Wozniak M, Nishizawa Y, Usukura J, Wakabayashi T. Opposite effects of microtubule-stabilizing and microtubule-destabilizing drugs on biogenesis of mitochondria in mammalian cells. J Cell Sci 2001; 114: 281 - 91. [12] Ke Y, Ye K, Grossniklaus HE, Archer DR, Joshi HC, Kapp JA. Noscapine inhibits tumor growth with little toxicity to normal tissues or inhibition of immune responses. Cancer Immunol Immunother 2000; 49: 217 - 25. [13] Kondo T, Habara Y, Kanno T, Kano E. Thermosensitization and modification of cytosolic calcium concentration by verapamil and diltiazem in mouse mammary carcinoma cells. Int J Radiat Oncol Biol Phys 1994; 29: 511 - 7. [14] Landen JW, Lang R, McMahon SJ, Rusan NM, Yvon AM, Adams AW, Sorcinelli MD, Campbell R, Bonaccorsi P, Ansel JC, Archer DR, Wadsworth P, Armstrong CA, Joshi HC. Noscapine alters microtubule dynamics in living cells and inhibits the progression of melanoma. Cancer Res 2002; 62: 4109 - 14. [15] Lazo JS, Schisselbauer JC, Herring GM, Kennedy KA. Involvement of the cellular vacuolar system with the cytotoxicity of bleomycin-like agents. Cancer Commun 1990; 2: 81 - 6. [16] Lederman G, Arbit E, Odaimi M, Wertheim S, Lombardi E. Recurrent glioblastoma multiforme: potential benefits using fractionated stereotactic radiotherapy and concurrent taxol. Stereotact Funct Neurosurg 1997; 69: 162 - 74. [17] Lee HC, Yin PH, Lu CY, Chi CW, Wei YH. Increase of mitochondria and mitochondrial DNA in response to oxidative stress in human cells. Biochem J 2000; 348: 425 - 32.
Vincristine canine dose
Stage 1 and 2: Surgical excision and chemotherapy Vincristine 0.04 mg kg IV Actinomycin D 75 microgram kg IV Chemotherapy is given before surgery, at 6 weeks post operatively, and then 3 months later Stage 1 ; or at 3, 6, 9, and 15 months later for Stage 2 and vivelle.
Saturating concentration of 22 jzM. In these experiments data not shown ; , the presence of vincristine did not affect the initial mateof methotrexate uptake, but caused an approximate 30% increase in the total intracellular level of methotrexate at 60
'1 ; DEPRESS AN TS ., Unless specifically excepted under, federal regulations or unless listed in another' schedule, any material, compound, mixture or preparation which contains any q uantity of the following substances having a depressant effect : on the central nervous system or their salts, isomers or- salts of isomers, if salts, isomers or salts of isomers exist under the specific chemical designation and voriconazole.
Study only reported in abstract form: the abstracts did not provide numbers of patients in each arm. A doxorubicin V vincristine C cyclophosphamide F 5-fluorouracil M methotrexate Mi mitomycin P melphalan T tamoxifen Pr prednisone H Halotestin fluoxymesterone ; Vb vinblastine E epirubicin and vincristine.
Nonvertebral fractures are one of the most serious consequences of osteoporosis, a disease of aging that disproportionately affects women. An estimated 75 million people in Europe, Japan, and the United States have osteoporosis, causing more than 2.3 million fractures annually in the United States and Europe alone.1 In 2002, an astounding 1 in 5 postmenopausal white women in the United States were calculated to have osteoporosis, and more than 1 in 2 were calculated to be at risk, having evidence of low bone density at the hip.2 An even more disturbing projection is that half of all white women in the United States will experience a fracture related to osteoporosis at some time in their lives.2 Statistics on the impact of osteoporosis and fractures due to osteoporosis are limited in African Americans and other minorities.3 However, fractures due to osteoporosis are underdiagnosed and undertreated in all populations.4 Bone loss increases with age in both genders, and the greater risk of osteoporosis among women is, in part, the result of longer life expectancy. As men live longer, the gender difference is expected to diminish. Currently, 1 in 5 individuals with osteoporosis is male, and 1 in 4 men 50 years of age will have a fracture due to this condition in his lifetime.4 Additionally, the existing disparities in prevalence from country to country are expected to equalize as life expectancy improves worldwide. Although the term "nonvertebral fracture" lacks a common definition among clinical trial reports, in a general sense it refers to any fracture not involving the spinal column. Nonvertebral fractures are more common than fractures of the vertebrae--an estimated 850, 000 nonvertebral compared with 700, 000 vertebral fractures occur annually in the United States. Nonvertebral fractures include more than 300, 000 hip and 250, 000 wrist fractures, in addition to 300, 000 fractures at other nonvertebral sites.5 Hip fractures are the most debilitating and costly to treat.1 Only 40% of individuals with hip fractures fully recover their prefracture degree of independence.2 Hip fractures are the leading cause of admission to long-term care facilities and may be required for as many as 1 in hip-fracture patients.2 In addition, hip fractures are associated with increased risk of death.2 Identifying elderly individuals at greatest risk of fractures is critical to reduce the impact of osteoporosis on personal and public health. Bone mineral density BMD ; is widely used to assess fracture risk.1 However, increasing evidence suggests that bone density is only one component of bone strength.1 Whereas BMD measures a single, albeit important, component of risk, previous fractures are a hallmark of osteoporosis, associated with at least a doubling of the risk for subsequent fractures.6 Implementation of practical and effective approaches for reducing the risk of fractures in the elderly requires a multidisciplinary effort among healthcare providers. This effort has been limited by the difficulty of integrating clinical trial data into clinical practice. The effects of nonpharmacologic, nutritional, and pharmacologic approaches on surrogate markers of fracture have not always reliably predicted clinical outcomes. The effects of pharmacologic interventions on fracture risk have been directly evaluated in several large clinical trials.7-18 Although the Hip Intervention Prevention HIP ; trial evaluated hip fracture rate as a primary end point, 14 no trial has evaluated nonvertebral sites in aggregate as such. As a result, statistically evaluable data from individual trials are limited. Moreover, comparisons among trials are complicated by differing definitions of nonvertebral fracture. In some, but not all trials, fractures at a limited number of nonvertebral sites were tracked, whereas, in others, all reported fractures were included in subsequent analysis. Additionally, some investigators defined fractures due to osteoporosis as those that would not have occurred in a healthy person with normal BMD.7-18 A recent meta-analysis has addressed this gap and has shown that some pharmacologic interventions can achieve statistically significant reductions in nonvertebral fracture risks Figure 1, page 2 ; . Efficacy was demonstrated in populations with relatively low incidence of nonvertebral fractures in the placebo group, suggesting that treatment benefit was not related to severity of osteoporosis.19 This Clinical Courier will discuss the importance of reducing the medical, economic, and societal impact of nonvertebral fractures. Efficacy data for antiresorptive therapy will be critically evaluated. 1 and vortex.
Vincristine pregnancy
Vincristine drug
Arimidex more drug_uses, mechanical ventilation textbook, digeorge syndrome karyotype, pondimin mexico and pacemaker definition. Intron bio, apoptosis quantification, maxillary sinus infection and lactose butter or retrospective appraisal.
Intrathecal vincristine
Cincristine, vicristine, vincristkne, vincris5ine, vincrixtine, vinctistine, vincristibe, vincristjne, v8ncristine, vincristnie, vimcristine, vncristine, vincristinee, vincrisine, fincristine, vibcristine, vkncristine, vvincristine, vincris6ine, vincristinne.
Intrathecal vincristine 2005 or 2006 or 2007 survey
How can vincristine be fatal to a cell, vincristine ventura, vincristine tabs, vincristine in canines and vincristine and hemangioma. Vincristine canine dose, vincristine pregnancy, vincristine drug and intrathecal vincristine or intrathecal vincristine 2005 or 2006 or 2007 survey.
|
